@article {7853,
	title = {Erratum: The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed/refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesis (Leukemia (2008) vol. 22 },
	journal = {Leukemia},
	volume = {22},
	year = {2008},
	note = {Cited By :1Export Date: 21 February 2017},
	month = {2008},
	pages = {2292},
	url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-57849108501\&doi=10.1038\%2fleu.2008.288\&partnerID=40\&md5=de28cc02806da82a0ea4ed0f6afc3580},
	author = {Terpos, E. and Kastritis, E. and Roussou, M. and Heath, D. and Christoulas, D. and Anagnostopoulos, N. and Eleftherakis-Papaiakovou, E. and Tsionos, K. and Croucher, P. and Dimopoulos, M.A.}
}
